Shangya Technology Co., Ltd. (TPEX:6130)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.80
0.00 (0.00%)
Jun 4, 2026, 9:54 AM CST
Market Cap1.01B -27.4%
Revenue (ttm)154.38M -22.0%
Net Income-73.18M
EPS-1.65
Shares Out 44.30M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume44,001
Open23.20
Previous Close22.80
Day's Range22.25 - 23.20
52-Week Range20.70 - 48.30
Beta0.21
Analystsn/a
Price Targetn/a
Earnings DateMay 27, 2026

About Shangya Technology

Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coated, yoyo flat mouth dissolved, and binlishu film-coated tablet, as well as pain relief capsules and yue shi tong injection. It is also involved in the ... [Read more]

Sector Healthcare
Founded 1994
Employees 31
Stock Exchange Taipei Exchange
Ticker Symbol 6130
Full Company Profile

Financial Performance

In 2025, Shangya Technology's revenue was 154.74 million, a decrease of -20.79% compared to the previous year's 195.35 million. Losses were -76.31 million, 128.3% more than in 2024.

Financial Statements